Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome | MicrobiomeTrials← Back to trialsNCT03905525
Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2019-10-01Est. Completion: 2022-09-28
Enrollment target: 273 participants Locations- North GA Rheumatology Group PC, Suwanee, Georgia, United States
- Indiana Univ School of Dentistry, Indianapolis, Indiana, United States
- Ochsner Health System, Baton Rouge, Louisiana, United States
- The John Hopkins Jerome L Greene Sjogren, Baltimore, Maryland, United States
- Tufts School of Dental Medicine, Boston, Massachusetts, United States
- Winthrop University Hospital, Mineola, New York, United States
- Perelman School of Medicine, Philadelphia, Pennsylvania, United States
- Uni Wisconsin School Med Pub Health, Madison, Wisconsin, United States
- Novartis Investigative Site, Buenos Aires, Argentina
- Novartis Investigative Site, CABA, Argentina
- Novartis Investigative Site, Nedlands, Western Australia, Australia
- Novartis Investigative Site, Graz, Austria
- Novartis Investigative Site, Vienna, Austria
- Novartis Investigative Site, Vitória, Espírito Santo, Brazil
- Novartis Investigative Site, Juiz de Fora, Minas Gerais, Brazil
- Novartis Investigative Site, São Paulo, São Paulo, Brazil
Other microbiome trials you might be interested in
Sjögren´s Disease
The purpose of this study is to demonstrate the efficacy and safety of ianalumab (VAY736) 300 mg administered subcutaneo…
Peoria, United StatesEst. completion Aug 14, 2029
Primary Sjögren SyndromeSarcopenia
The aim of this study is to evaluate the frequency of probable sarcopenia and sarcopenia in patients with primary Sjögre…
Antalya, Turkey (Türkiye)Est. completion Jul 20, 2025
Novartis Investigative Site, Toronto, Ontario, CanadaNovartis Investigative Site, Rimouski, Quebec, CanadaNovartis Investigative Site, Trois-Rivières, Quebec, CanadaNovartis Investigative Site, Valdivia, Los Ríos Region, ChileNovartis Investigative Site, Santiago, RM, ChileNovartis Investigative Site, Santiago, Santiago Metropolitan, ChileNovartis Investigative Site, Santiago, Santiago Metropolitan, ChileNovartis Investigative Site, Concepción, ChileNovartis Investigative Site, Medellín, Antioquia, ColombiaNovartis Investigative Site, Barranquilla, Atlántico, ColombiaNovartis Investigative Site, Cali, Valle del Cauca Department, ColombiaNovartis Investigative Site, Brest, FranceNovartis Investigative Site, Le Kremlin-Bicêtre, FranceNovartis Investigative Site, Lille, FranceNovartis Investigative Site, Paris, FranceNovartis Investigative Site, Strasbourg, FranceNovartis Investigative Site, Freiburg im Breisgau, Baden-Wurttemberg, GermanyNovartis Investigative Site, Würzburg, Bavaria, GermanyNovartis Investigative Site, Dresden, Saxony, GermanyNovartis Investigative Site, Bonn, GermanyNovartis Investigative Site, Athens, GreeceNovartis Investigative Site, Székesfehérvár, Fejér, HungaryNovartis Investigative Site, Budapest, HungaryNovartis Investigative Site, Szeged, HungaryNovartis Investigative Site, Haifa, IsraelNovartis Investigative Site, Kfar Saba, IsraelNovartis Investigative Site, Ramat Gan, IsraelNovartis Investigative Site, Milan, MI, ItalyNovartis Investigative Site, Pisa, PI, ItalyNovartis Investigative Site, Udine, UD, ItalyNovartis Investigative Site, Nagoya, Aichi-ken, JapanNovartis Investigative Site, Sasebo, Nagasaki, JapanNovartis Investigative Site, Kurashiki, Okayama-ken, JapanNovartis Investigative Site, Chuo Ku, Tokyo, JapanNovartis Investigative Site, Shinjuku-ku, Tokyo, JapanNovartis Investigative Site, Rotterdam, South Holland, NetherlandsNovartis Investigative Site, Groningen, NetherlandsNovartis Investigative Site, Almada, PortugalNovartis Investigative Site, Lisbon, PortugalNovartis Investigative Site, Lisbon, PortugalNovartis Investigative Site, Ponte de Lima, PortugalNovartis Investigative Site, Brasov, RomaniaNovartis Investigative Site, Cluj-Napoca, RomaniaNovartis Investigative Site, Kazan', RussiaNovartis Investigative Site, Moscow, RussiaNovartis Investigative Site, Orenburg, RussiaNovartis Investigative Site, Saint Petersburg, RussiaNovartis Investigative Site, Tomsk, RussiaNovartis Investigative Site, Yekaterinburg, RussiaNovartis Investigative Site, Seoul, Seocho Gu, South KoreaNovartis Investigative Site, Stockholm, SE, SwedenNovartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)Novartis Investigative Site, Birmingham, United KingdomNovartis Investigative Site, Doncaster, United KingdomNovartis Investigative Site, Manchester, United KingdomPhase 1
Recruiting
SjögrenSjogren DiseaseSjogren's Syndrome
A phase 1b, open-label study of CLN-978 administered subcutaneously in patients with active, moderate to severe Sjogren'…
Orlando, United StatesEst. completion Mar 15, 2028